T 0062/16 (Leuprolide/ TOLMAR) of 14.02.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T006216.20190214
- Date of decision
- 14 February 2019
- Case number
- T 0062/16
- Petition for review of
- -
- Application number
- 09012462.9
- IPC class
- A61K 47/34A61K 38/09A61K 9/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Polymeric delivery formulations of leuprolide with improved efficacy
- Applicant name
- Tolmar Therapeutics, Inc.
- Opponent name
- Generics (U.K.) Limited (trading as Mylan)
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56European Patent Convention Art 99(1)Rules of procedure of the Boards of Appeal Art 13(3)
- Keywords
- Admissibility of opposition - (yes)
Inventive step - main and auxiliary requests (no) - Catchword
- -
- Cited cases
- T 1714/12
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.